Oncogenic viruses, cancer biology, and innate immunity

Malignancies that arise as a result of viral infection account for roughly 15% of cancer cases worldwide. The innate immune system is the body's first line of defense against oncogenic viral infection and is also involved in the response against viral -driven tumors. In this review, we discuss research advances made over the last five years elucidating how the innate immune system recognizes and responds to oncogenic viruses, how these viruses have evolved to escape this immune pressure, and ways that innate immunity can inform the development of novel therapeutics against oncogenic viral infection and their associated cancers.

Automated summary

This review discusses recent advances in understanding how the innate immune system recognizes and responds to oncogenic viruses, and how these viruses have evolved to evade the immune system. It also explores how innate immunity can be utilized in the development of novel therapeutics against oncogenic viral infections and associated cancers.